Journals / Journal of Neurological Sciences (Turkish) / 2013 / Cilt: 30 - Sayı: 4

Akut Periferik Sinir Yaralanmasının Tedavisinde Nikergolinin Akut Dönem Etkilerinin Değerlendirilmesi

Evaluation of the Acute Period Effects of Nicergoline in the Management of Acute Peripheral Nerve Injury

Pages
651–659
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Tissue tumor necrosis factor-α, myeloperoxidase, malondialdehyde, andnerve growth factor levels showed significant differences between all groups.Discussion: Nicergoline showed statistically significant effects in the management of acuteperipheral nerve injury at the acute period.Conclusion: Nicergoline may be used in the management of peripheral nerve injuries,especially in the cases that are not good candidates for surgery, at least as an adjuvant therapy.However, this study must be supported by new ones having histopathological bases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The purpose of this study is to evaluate the acute period effects of nicergoline, hasan effect on increasing local blood flow, in the management of acute peripheral nerve injury.Materials and methods: Study was performed on Wistar albino rats weighing about 200-250grams by developing sciatic nerve injury with medium pressured smooth aneurysm clip.
📊
Key Findings & Data:In the third group, after performing sciaticnerve injury rats were given low-dose nicergoline for 7 days.
💡
Conclusion & Impact:Tissue tumor necrosis factor-α, myeloperoxidase, malondialdehyde, andnerve growth factor levels showed significant differences between all groups.Discussion: Nicergoline showed statistically significant effects in the management of acuteperipheral nerve injury at the acute period.Conclusion: Nicergoline may be used in the management of peripheral nerve injuries,especially in the cases that are not good candidates for surgery, at least as an adjuvant therapy.However, this study must be supported by new ones having histopathological bases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The purpose of this study is to evaluate the acute period effects of nicergoline, hasan effect on increasing local blood flow, in the management of acute peripheral nerve injury.Materials and methods: Study was performed on Wistar albino rats weighing about 200-250grams by developing sciatic nerve injury with medium pressured smooth aneurysm clip. Ratsdivided into four groups each containing ten animals. In the first group, only sciatic nervedissection was performed, control group. In second group, sciatic nerve injury was performedand animals were leaved to spontaneous healing. In the third group, after performing sciaticnerve injury rats were given low-dose nicergoline for 7 days. In the fourth group, after sciaticnerve injury rats were given high dose nicergoline for 7 days. Before sacrification, for theassessing of sciatic nerve functional index, walking track analysis was performed. In thesciatic nerve tissue samples, interleukin-10, myeloperoxidase, tumor necrosis factor alpha,nerve growth factor, malondialdehyde levels were measured. For the statistical analysis,Mann-Whitney U test was used and the values lesser than 0.05 was accepted as statisticallysignificant.Results: Sciatic nerve functional index showed statistically significant difference between allgroups. Tissue interleukin-10 levels showed significant differences between all groups exceptgroup III and IV. Tissue tumor necrosis factor-α, myeloperoxidase, malondialdehyde, andnerve growth factor levels showed significant differences between all groups.Discussion: Nicergoline showed statistically significant effects in the management of acuteperipheral nerve injury at the acute period.Conclusion: Nicergoline may be used in the management of peripheral nerve injuries,especially in the cases that are not good candidates for surgery, at least as an adjuvant therapy.However, this study must be supported by new ones having histopathological bases.

Özet

Amaç: Bu çalışmanın amacı akut periferik sinir hasarında yerel kan akımını artırıcı etkiyesahip olan nikergolinin akut dönemdeki etkilerinin incelenmesidir.Yöntem ve gereçler: Çalışma ağırlıkları 200-250 gram arasında değişen Wistar albino cinsisıçanlarda orta basınçı anevrizma klibi ile periferik sinir hasarı oluşturularak yapılmıştır. Sıçanlar her bir grupta 10 denek olacak şekilde dört gruba ayrıldı. Birinci grup kontrol grubuolup, bu grupta sadece siyatik sinir disseksiyonu yapıldı. Ikinci grupta siyatik sinirdisseksiyonunu takiben klip ile sinir hasarı oluşturuldu. Üçüncü grupta sinir hasarıoluşturulduktan sonra 7 gün boyunca düşük doz nikergolin verildi. Dördüncü grupta ise hasarsonrası 7 gün boyunca yüksek doz nikergolin verildi. Sıçanlar sekizinci gün denekler yürümetestine tabi tutularak siyatik sinir fonksiyonel endeksleri hesaplandı. Sonrasında deneklerinsiyatik sinir dokuları alındı ve bu dokularda interlökin-10, miyeloperoksidaz, tümörnekrotizan faktör, sinir büyüme faktörü ve malondialdehid düzeyleri bakıldı. İstatikselanalizde Mann-Whitney U testi kullanıldı. İstatiksel olarak 0,05'den küçük değerler anlamlıolarak kabul edildi.Sonuçlar: Siyatik sinir fonksiyonel endeksi tüm gruplar arasında istatiksel olarak anlamlıfarklılık gösterdi. Doku interlökin-10 düzeyi grup III ve IV arasında hariç olmak üzere tümgruplar arasında anlamlı farklılık gösterdi. Doku tümör nekrotizan faktör alfa,miyeloperoksidaz, malondialdehid ve sinir büyüme faktörü düzeyleri tüm gruplar arasındaanlamlı farklılık gösterdi.Tartışma: Nikergolin akut periferik sinir hasarının tedavisinde akut dönemde istatiksel olarakanlamlı düzeyde iyileştirici etki göstermiştir.Sonuç: Nikergolin özellikle cerrahi için aday olamayan hastalarda periferik sinir hasarınıntedavisinde kullanılabilir. Bununla birlikte, bu çalışmanın histopatolojik destekli ekçalışmalarla desteklenmesi gerekmektedir.

🔖

Cite This Article

AK, H., SERTER, M., AYDIN, V., GÖÇMEN, A. Y., YALÇIN, S. S. (2022). Akut Periferik Sinir Yaralanmasının Tedavisinde Nikergolinin Akut Dönem Etkilerinin Değerlendirilmesi. Journal of Neurological Sciences (Turkish), Cilt: 30 - Sayı: 4, 651–659. https://ajindex.com/articles/565101

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Barbosa RI, Marcolino AM, de Jesus Guirro RR, Mazzer N, Barbieri CH, de Cássia Registro Fonseca M. Comp arative eff ects of wavelengths of low-p ower laser in regeneration of sciatic nerve in rats f ollowing crushing lesion. Lasers Med Sci 2010 25:423–430
  2. Buhroo AM. Observations on rehabilitation of p erip heral nerve inj uries in Kashmir Valley. IJPMR 2003; 14: 27-32 3. Caraci F, Chisari M, Frasca G, Canonico PL, Battaglia A, Calaf iore M, Battaglia G, Bosco P, Nicoletti F, Cop ani A, Sortino. Nicergoline, a drug used f or age-dep endent cognitive imp airment, p rotects cultured neurons against β-amyloid toxicity. Brain Research 2005; 1047: 30-7
  3. Echeverry S, Shi X O, Haw A, Liu H, Zhang ZW, Zhang J. Transf orming growth f actor-beta1 imp airs neurop athic p ain through p leiotrop ic eff ects. Molecular Pain. 2009; 27;5:16
  4. Eskdale J, Kube D, Tesch H, Gallagher G. Mapp ing of the human IL10 gene and f urther characterization of the 5' f lanking sequence. Immunogenetics. 1997;46(2):120 128
  5. Fenrich, K., T. Gordon. Axonal Regeneration in the Perip heral and Central Nervous Systems - Current Issues and Advances. Canadian J Neuro Sci 2004 31(2): p. 142-156
  6. Harding KG, Morris HL, Patel GK. Healing chronic wounds. BMJ 2002; 324: 160-3
  7. Hollerman JJ, Fackler ML, Coldwell, Ben- Menachem. Gunshot wounds: 1. Bullets, ballistics, and mechanisms of inj ury. AJR 1990; 155: 685-90
  8. Iliff LD, Boulay GHD, Marshall J, Russell R WR, Symon L. Eff ect of nicergoline on cerebral blood f low. Journal of Neurology, Neurosurgery and Psychiatry 1977; 49: 746-7
  9. İmer M. Travmatik p erif erik sinir yaralanmaları. Aksoy K (ed). Temel Nöroşirurj i Cilt 2. 1. baskı. Ankara: Buluş tasarım ve matbaacılık, 2005: 1251-9
  10. Jancalek R, Dubovy P, Svizenska I, Klusakova I. Bilateral changes of TNF-α and IL-10 p rotein in the lumbar and cervical dorsal root ganglia f ollowing a unilateral chronic constriction inj ury of the sciatic nerve. Journal of Neuroinf lammation 2010, 7:11
  11. Jonsson K, Jensen A, Goodson WH, Scheuenstuhi H, West J, Hopf H W, Kunt T. Tissue oxygenation, anemia, and p erf usion in relation to wound healing in surgical p atients. Ann. Surg, 1991; 605-13
  12. Kemp SW, Webb AA, Dhaliwal S, Syed S. Walsh S.K. Midha R. Dose and duration of nerve growth f actor (NGF) administration determine the extent of behavioral recovery f ollowing p erip heral nerve inj ury in the rat. Exp. Neurol. 2011; 229: 460-470
  13. Kim SY, Yang J, Lee YC. The e